Periodic monitoring Active

Key facts

  • In October 2024, 27 countries reported measles data to EpiPulse Cases, with 181 cases reported by 13 countries. There were 14 countries that reported zero cases
  • Through its epidemic intelligence activities, ECDC has identified 267 measles cases in six EU countries that have not been reported to ECDC or were reported since the last monthly update.
  • In 2024, 19 measles-related deaths have been reported in Romania (18) and Ireland (1).
  • Overall in the EU/EEA, over the last 12 months, there has been high measles activity; however, the situation varies by country. Some countries have reported large and/or ongoing outbreaks and others have reported no sustained or very low transmission.

Overview

In October 2024, 27 countries reported measles data to EpiPulse Cases, with 181 cases reported by 13 countries. There were 14 countries that reported zero cases.

In the most recent 12-month period, from 1 November 2023 to 31 October 2024, 30 EU/EEA Member States reported a total of 18 044 cases of measles. Between 1 November 2023 and 31 October 2024, of the 18 044 cases with known age, 7 978 (44.2%) were in children under five years of age; and 5 165 (28.6%) cases were aged 15 years or older. The highest notification rates were observed in infants under one year of age (579.3 cases per million) and children aged 1-4 years (337.9 cases per million). Of 15 163 cases (100.0% of all cases) with a known age and vaccination status, 13 228 (87.2%) were unvaccinated, 1 256 (8.3%) were vaccinated with one dose of a measles-containing vaccine, 634 (4.2%) were vaccinated with two or more doses, and 25 (0.2%) were vaccinated with an unknown number of doses. Thirteen deaths (case fatality rate (CFR): 0.1) attributable to measles were reported to ECDC during the 12-month period by Romania (12) and Ireland (one)

Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases.

Complementary epidemic intelligence surveillance, with data collection conducted on 9 December 2024 from official public and media sources, detected 199 suspected and/or confirmed measles cases not reported in ECDC’s monthly measles and rubella monitoring report and 68 new measles cases reported since the last monthly update. New cases were reported in six EU countries: Austria (new: 3; total: 509), Czechia (new: 1, total: 34), Germany (new: 220; total: 636), Hungary (new: 1, total: 31), Ireland (new: 40, total: 18), Lithuania (new: 2, total: 30).

No measles-related deaths have been reported in recent months. Overall, 19 measles-related deaths have been reported in the EU/EEA in 2024, in Romania (18) and in Ireland (1).

Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to TESSy and EpiPulse Cases. Data presented in the two monthly reports may differ.

Epidemiological summary for EU/EEA countries with relevant epidemic intelligence updates:

Austria reported 509 confirmed measles cases in 2024 and as of 3 December 2024, an increase of three cases since 12 November 2024.

Czechia reported zero measles cases in September and October 2024. One measles case was reported in November 2024 and as of 1 December 2024, 34 measles cases have been reported in 2024.

Germany reported 199 cases in September and October 2024 (weeks 33-44). Overall, 636 measles cases have been reported in 2024 (data as of 9 December 2024), with 21 cases reported in weeks 45-49.

Hungary reported 31 measles cases in 2024 and as of 1 December 2024, an increase by one case since 3 November 2024.

Ireland reported 187 measles cases in 2024 (data as of 30 November 2024), an increase of 40 cases since 6 November 2024.

Latvia reported no measles cases in 2024 and as of 26 November 2024.

Lithuania reported 30 cases in 2024 (data as of 9 December 2024), an increase by two cases since 6 November 2024.

Summary of measles cases reported by WHO regional offices (as of 7 November 2024)

Note: Thus summary was provided in the last measles monthly update and is still the latest summary available.

WHO Regional Office for Europe (WHO/EUROPE) reported 95 204 measles cases in 2024. The five non-EU/EEA countries reporting the most measles cases were: Kazakhstan (27 760), Azerbaijan (16 675), the Russian Federation (14 751), Kyrgyzstan (12 587), and the United Kingdom (2 398).

 

The numbers provided to WHO for EU/EEA countries are from TESSy data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.

 

WHO Regional Office for Africa (WHO AFRO) has reported 67 976 measles cases in 2024. The highest numbers of cases were reported from Ethiopia (26 493), Nigeria (8 243), Burkina Faso (6 457), Cote d’Ivoire (6 048) and the Democratic

Republic of the Congo (4 149).

 

WHO Regional Office for the Americas (WHO PAHO) has reported 342 measles cases in 2024. Most cases (238) were reported in the United States.

WHO Regional Office for the Eastern Mediterranean (WHO EMRO) has reported 80 607 measles cases in 2024. The highest numbers of cases were reported from Iraq (30 889), Pakistan (21 070), Yemen (17 730), Afghanistan (7 023), and Somalia (1 119).

WHO Regional Office for South-East Asia (WHO SEARO) has reported 24 541 measles cases in 2024. The highest numbers of cases were reported from India (16 934), Indonesia (4 145), Thailand (2 694), Sri Lanka (242), and Nepal (201).

WHO Regional Office for the Western Pacific (WHO WPRO) has reported 7 137 measles cases in 2024. The following five countries reported the most cases: the Philippines (3 346), Malaysia (2 647), China (665), Vietnam (347), and the Republic of Korea (47).

ECDC assessment

The overall number of measles cases in the EU/EEA has been steadily increasing since June 2023. However, for the month of October 2024, there was a decrease in the number of cases reported. Measles cases may continue to increase in the EU/EEA in the coming months. This is due to reported sub-optimal vaccination coverage for measles-containing vaccines (MCV) in a number of EU/EEA countries (<95% in many of these countries), as well as a high probability of importation from areas experiencing high circulation. In addition, the majority of recently reported cases have acquired the disease within the reported country through community/local transmission, indicating a higher probability of being exposed to the virus within the EU/EEA than in previous months.

As the number of cases is expected to rise in the near future, ECDC urges EU/EEA public health authorities to focus on the following areas:

  • Close immunity gaps, achieve and maintain high vaccination coverage for MCV (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
  • Strive towards high-quality surveillance, and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
  • Increase the clinical awareness of health professionals.
  • Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of sub-optimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
  • Address barriers and engage with underserved populations. Systemic barriers that impact vaccine uptake in under-served, isolated and difficult-to-reach populations need to be monitored and addressed with targeted strategies, to reduce inequalities in vaccine uptake.


ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response' published in February 2024 and the conclusions of that remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.  

Actions

ECDC is monitoring the measles situation through its epidemic intelligence activities, which supplement monthly outputs with measles surveillance data from TESSy, routinely submitted by 30 EU/EEA countries. ECDC's latest advice on measles is available in the Threat Assessment Brief, 'Measles on the rise in the EU/EEA: Considerations for a public health response', published on 15 February 2024.

Latest updates for this event

View all